Jane Street’s CorMedix CRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.14M Buy
+145,146
New +$1.15M ﹤0.01% 6254
2026
Q1
Sell
-274,630
Closed -$2.03M 11775
2025
Q4
$3.19M Buy
274,630
+62,961
+30% +$696K ﹤0.01% 3949
2025
Q3
$2.46M Sell
211,669
-74,291
-26% -$898K ﹤0.01% 4558
2025
Q2
$3.52M Buy
+285,960
New +$3.16M ﹤0.01% 3502
2025
Q1
Sell
-26,861
Closed -$278K 9577
2024
Q4
$218K Sell
26,861
-91,993
-77% -$919K ﹤0.01% 8277
2024
Q3
$960K Sell
118,854
-2,734
-2% -$14.8K ﹤0.01% 5975
2024
Q2
$526K Buy
121,588
+101,533
+506% +$516K ﹤0.01% 6937
2024
Q1
$85K Sell
20,055
-43,555
-68% -$151K ﹤0.01% 8583
2023
Q4
$239K Buy
63,610
+31,670
+99% +$109K ﹤0.01% 7962
2023
Q3
$118K Buy
+31,940
New +$127K ﹤0.01% 7879
2023
Q2
Sell
-95,882
Closed -$474K 8789
2023
Q1
$397K Buy
+95,882
New +$392K ﹤0.01% 6726
2021
Q3
Sell
-11,981
Closed -$82K 10011
2021
Q2
$82K Sell
11,981
-24,050
-67% -$191K ﹤0.01% 9347
2021
Q1
$360K Buy
+36,031
New +$379K ﹤0.01% 7397
2019
Q4
Sell
-15,153
Closed -$97K 5129
2019
Q3
$97K Buy
+15,153
New +$127K ﹤0.01% 4800
2015
Q3
Sell
-3,788
Closed -$73K 3639
2015
Q2
$73K Buy
+3,788
New +$130K ﹤0.01% 3483

Other funds holding CRMD

Jane Street's CRMD Position: Q2 2026 in Review

Jane Street opened a new position in CorMedix (CRMD) in Q2 2026: 145,146 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #6254 among its holdings. This is a return to the name: Jane Street previously reported a position in CRMD as recently as Q4 2025.

Jane Street first reported a position in CRMD in Q2 2015 and has held it in 15 quarters since. The position peaked at $3.52M in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Jane Street held 145,146 shares of CorMedix worth $1.14M as of Q2 2026.
  • CorMedix was a new Jane Street position in Q2 2026.
  • CorMedix made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6254 holding.
  • Jane Street first reported a position in CorMedix in Q2 2015 and has held it in 15 quarters since.
  • Jane Street's CorMedix position peaked at $3.52M in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.